» Articles » PMID: 29743814

MicroRNA-365 Promotes Lung Carcinogenesis by Downregulating the USP33/SLIT2/ROBO1 Signalling Pathway

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2018 May 11
PMID 29743814
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Abnormal microRNA expression is closely related to cancer occurrence and development. miR-365a-3p plays an oncogenic role in skin cancer, but its role in lung cancer remains unclear. In this study, we aimed to investigate its role and underlying molecular mechanisms in lung cancer.

Methods: Western blot and real-time quantitative PCR (qPCR) were used to detect the expression of miR-365a-3p in lung adenocarcinoma and lung cancer cell lines. The effects of miR-365a-3p on lung cancer cell proliferation, migration, and invasion were also explored in vitro. The potential miR-365a-3p that targets was determined by dual luciferase reporter assay and verified by qPCR and western blot analysis. miR-365a-3p acts as an oncogene by promoting lung carcinogenesis via the downregulation of the miR-365a/USP33/SLIT2/ROBO1 axis based on western blot analysis. Subcutaneous tumourigenesis further demonstrated that miR-365a-3p promotes tumour formation in vivo.

Results: miR-365a-3p was upregulated in lung adenocarcinoma and lung cancer cell lines. Overexpression of miR-365a-3p promoted and inhibition of miR-365a-3p suppressed the proliferation, migration, and invasion of lung cancer cells. We identified as the downstream target of miR-365a-3p and observed a negative correlation between miR-365a-3p and expression in lung adenocarcinoma patients. The miR-365/USP33/SLIT2/ROBO1 axis, a new mechanism, was reported to inhibit the invasion and metastasis of lung cancer. A nude mouse model of lung cancer further verified these findings.

Conclusions: In summary, miR-365a-3p acts as an oncogene by promoting lung carcinogenesis via the downregulation of the USP33/SLIT2/ROBO1 signalling pathway, making the miR-365/USP33/SLIT2/ROBO1 axis a new mechanism of lung cancer promotion and a novel therapeutic target for predicting prognosis and response to gene therapy.

Citing Articles

MiR-365-3p inhibits lung cancer proliferation and migration via CPT1A-mediated fatty acid oxidation.

Xu D, Liu B, Wang L Sci Rep. 2025; 15(1):7076.

PMID: 40016582 PMC: 11868381. DOI: 10.1038/s41598-025-91665-x.


USP33 is an integrin α6 deubiquitinase and promotes esophageal squamous cell carcinoma cell migration and metastasis.

Hang Q, Zuo S, Yang Y, Wang Y, Li C, Li W J Cancer Res Clin Oncol. 2024; 150(12):511.

PMID: 39589547 PMC: 11599434. DOI: 10.1007/s00432-024-06041-5.


Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas.

Ge J, Ge J, Tang G, Xiong D, Zhu D, Ding X J Transl Med. 2024; 22(1):775.

PMID: 39152432 PMC: 11328457. DOI: 10.1186/s12967-024-05590-0.


Harnessing HEK293 cell-derived exosomes for hsa-miR-365a-3p delivery: Potential application in hepatocellular carcinoma therapy.

Ghotaslou A, Azizsoltani A, Baghaei K, Alizadeh E Heliyon. 2024; 10(8):e29333.

PMID: 38638994 PMC: 11024613. DOI: 10.1016/j.heliyon.2024.e29333.


Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis.

Xue Y, Xue C, Song W Cell Oncol (Dordr). 2024; 47(4):1071-1089.

PMID: 38324230 DOI: 10.1007/s13402-024-00923-z.


References
1.
Li J, DAngiolella V, Seeley E, Kim S, Kobayashi T, Fu W . USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. Nature. 2013; 495(7440):255-9. PMC: 3815529. DOI: 10.1038/nature11941. View

2.
Vannini I, Fanini F, Fabbri M . MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis. Clin Biochem. 2013; 46(10-11):918-25. DOI: 10.1016/j.clinbiochem.2013.01.024. View

3.
Kumar M, Erkeland S, Pester R, Chen C, Ebert M, Sharp P . Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A. 2008; 105(10):3903-8. PMC: 2268826. DOI: 10.1073/pnas.0712321105. View

4.
Mertsch S, Schmitz N, Jeibmann A, Geng J, Paulus W, Senner V . Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J Neurooncol. 2007; 87(1):1-7. DOI: 10.1007/s11060-007-9484-2. View

5.
Zhou L, Wang Y, Ou C, Lin Z, Wang J, Liu H . microRNA-365-targeted nuclear factor I/B transcriptionally represses cyclin-dependent kinase 6 and 4 to inhibit the progression of cutaneous squamous cell carcinoma. Int J Biochem Cell Biol. 2015; 65:182-91. DOI: 10.1016/j.biocel.2015.06.009. View